Literature DB >> 8942335

Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?

M J Baurain1, F Hoton, A A D'Hollander, F R Cantraine.   

Abstract

To test if recovery of neuromuscular transmission is complete after the use of neostigmine under standardized conditions, we have measured adductor pollicis mechanical activity in response to 0.1 Hz (twitch height), train-of-four (TOF) and 100 Hz (RF 100 Hz) ulnar nerve stimulations. We studied 56 adult anaesthetized (thiopentone, fentanyl, nitrous oxide in oxygen) patients, allocated randomly to one of four groups (n = 14) to receive rocuronium (group Roc), vecuronium (group Vec), atracurium (group Atr) or pancuronium (group Pan). Recovery of neuromuscular transmission was studied for 15 min after neostigmine 40 micrograms kg-1 was given at 25% recovery of twitch height. Fifteen minutes after antagonism, the TOF ratio was 0.91 (SEM 0.01), 0.88 (0.02) and 0.92 (0.01) (ns), and RF 100 Hz was 0.78 (0.01), 0.79 (0.02) and 0.78 (0.01) (ns) respectively, in patients in groups Roc, Vec and Atr, respectively. In patients in group Pan, TOF ratio and RF 100 Hz were only 0.76 (0.01) and 0.33 (0.04) respectively (P < 0.01, one-way analysis of variance, Duncan's multiple classification range tests). In contrast with pancuronium, antagonism of rocuronium-, vecuronium- and atracurium-induced neuromuscular blocks produced a similar high degree of recovery of neuromuscular transmission.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942335     DOI: 10.1093/bja/77.4.496

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  1 in total

1.  Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function.

Authors:  Matthias Eikermann; Philipp Fassbender; Atul Malhotra; Masaya Takahashi; Shigeto Kubo; Amy S Jordan; Shiva Gautam; David P White; Nancy L Chamberlin
Journal:  Anesthesiology       Date:  2007-10       Impact factor: 7.892

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.